Concepedia

Gabriel Birkuš

GB

Statistics

Publications

32

Citations

2.4K

H-Index

25

Active since

1995

Affiliations

Gilead Sciences (United States)(Current)

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry

Charles University

Czech Academy of Sciences

Palacký University Olomouc

Gabriel Birkuš is an author at Gilead Sciences (United States) specializing in pharmacology, life sciences, and enzyme inhibition.

ORCID

Publications per year

1995–2017

32

Publications

32

Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors

Gabriel Birkuš, Michael J. M. Hitchcock, Tomáš Cihlář · Antimicrobial Agents and Chemotherapy · 2002 · 441 citations · Full text

, , +17

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia et al. · Kidney International · 2014 · 244 citations · Full text

, , +17

Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design

E.B. Lansdon, Katherine M. Brendza, Magdeleine Hung et al. · Journal of Medicinal Chemistry · 2010 · 226 citations

, , +17

Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131

Gabriel Birkuš, Ruth Wang, Xiaohong Liu et al. · Antimicrobial Agents and Chemotherapy · 2006 · 173 citations · Full text

, , +15

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors

Tomáš Cihlář, Gabriel Birkuš, Dale E. Greenwalt et al. · Antiviral Research · 2002 · 123 citations

, , +11

1–5 of 32